Search filters
Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

The COvid19 VaccinE Response in Rheumatology Patients (COVER)

99 years or below
All genders
This study is designed to evaluate the efficacy and safety of SARS-CoV-2 vaccines in patients with autoimmune conditions and to evaluate the impact of different immunomodulatory therapies on vaccine response. Adults with psoriatic arthritis (PsA), axial spondyloarthritis (SpA) and rheumatoid arthritis (RA) will be enrolled. The study involves data and …
Learn More

A 6-month prospective randomized double-blind placebo-controlled clinical trial investigating the efficacy safety and tolerability of two different doses of buntanetap or placebo in patients with early Parkinsons disease

99 years or below
All genders
A double-blind study to investigate efficacy and safety of buntanetap compared with placebo in participants with early PD
Learn More

Alzheimers Disease Neuroimaging Initiative 4

99 years or below
All genders
The aim of the Alzheimers Disease Neuroimaging Initiative (ADNI) has been to validate biomarkers for Alzheimers disease (AD) clinical trials. ADNI4 continues the previously funded ADNI1, ADNI-GO, ADNI2, and ADNI3 studies that have combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic …
Learn More

Assessing Diagnostic Predictors of Airway Collapse in patients with Obstructive Sleep Apnea

99 years or below
All genders
This study is a multicenter study of up to 300 subjects diagnosed with OSA who are being evaluated for airway surgery, including hypoglossal nerve stimulation. Subjects will undergo standard evaluation for airway surgery as part of standard of care. In addition, a simple, non-invasive measurement of the pharyngeal width (PW) …
Learn More

Identification of culturally responsive and unresponsive mental healthcare

99 years or below
All genders
Systemic and interpersonal discrimination has led to Black, Indigenous, and People of Color and lesbian, gay, bisexual, transgender, and queer individuals facing high rates of psychological distress. We will use a mixed methods design to gain rich contextual information on therapist behaviors and relational processes informing culturally responsive and unresponsive …
Learn More

An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

99 years or below
All genders
This study is the OLE of the Main study currently ongoing. Targeted population are those individuals who completed the original study. Study procedures include physical exams, safety labs, ECGs, breathing tests, and questionnaires.
Learn More

UPCC 38422: Phase 3 Multicenter Double-Blind Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant

99 years or below
All genders
A study to evaluate posoleucel (ALVR105); an allogeneic, off-the-shelf multi-virus specific T cell therapy that targets six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus. We would like to rely on WCG as the IRB of record for this study.
Learn More

A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once daily for the Treatment of HIV-1 Infection in subjects Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study

99 years or below
All genders
This trial is testing doravirine/islatravir (also known as MK-8591A or DOR/ISL) in people living with HIV-1 who have participated in another Merck-sponsored trial of DOR/ISL. The main purpose of this trial is to test the safety and efficacy of DOR/ISL and give patients continued access to DOR/ISL through this rollover …
Learn More

A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism (ENGULF)

99 years or below
All genders
Please see section 4 of the full protocol Please see section 4 of the full protocol Please see section 4 of the full protocol
Learn More

A Phase 1 Open-Label Safety Pharmacokinetic and Preliminary Efficacy Study of STRO-002 an Anti-Folate Receptor alpha (FolR) Antibody Drug Conjugate (ADC) in Combination with Bevacizumab in Patients with Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers)

99 years or below
All genders
Phase 1
To evaluate the safety and tolerability of STRO-002/bevacizumab as a combination therapy. To further evaluate the toxicity and tolerability of STRO-002/bevacizumab in patients with Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) To characterize the PK of STRO-002 when administered with bevacizumab To assess the immunogenic potential …
Learn More
571 - 580 of 1202